Oncternal Therapeutics | 10-Q: Q3 2024 Earnings Report
Oncternal Therapeutics | 10-Q: Q2 2024 Earnings Report
Oncternal Therapeutics | 8-K: Oncternal Therapeutics Provides Business Update and Announces Second Quarter 2024 Financial Results
Oncternal Therapeutics | 10-Q: Q1 2024 Earnings Report
Oncternal Therapeutics | 8-K: Oncternal Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results
Oncternal Therapeutics | 10-K: FY2023 Annual Report
Oncternal Therapeutics | 8-K: Oncternal Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results
Oncternal Therapeutics | 10-Q: Q3 2023 Earnings Report
Oncternal Therapeutics | 8-K: Oncternal Therapeutics Provides Business Update and Announces Third Quarter 2023 Financial Results
Oncternal Therapeutics | 10-Q: Q2 2023 Earnings Report
Oncternal Therapeutics | 8-K: Oncternal Therapeutics Provides Business Update and Announces Second Quarter 2023 Financial Results
Oncternal Therapeutics | 10-Q: Q1 2023 Earnings Report
Oncternal Therapeutics | 8-K: Oncternal Therapeutics Provides Business Update and Announces First Quarter 2023 Financial Results
Oncternal Therapeutics | 10-K/A: Annual report (Amendment)
Oncternal Therapeutics | 10-K: FY2022 Annual Report
Oncternal Therapeutics | 8-K: Oncternal Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2022 Financial Results
Oncternal Therapeutics | 10-Q: Q3 2022 Earnings Report
Oncternal Therapeutics | 8-K: Oncternal Therapeutics Provides Business Update and Announces Third Quarter 2022 Financial Results
Oncternal Therapeutics | 10-Q: Q2 2022 Earnings Report
Oncternal Therapeutics | 8-K: Oncternal Therapeutics Provides Business Update and Announces Second Quarter 2022 Financial Results
Unlock the Full List